Stock & Company Details
City Therapeutics $CTY
Price:
N/A
N/A
N/A
$1.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
N/A
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
CTY technical indicators
Latest City Therapeutics (CTY) indicator readings as of 2026-10-29.
Overview
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.
Signal:
Volatility: N/A
Sentiment:
Finance Bot
🤖
Ask your questions
Start by typing a question below.
